Osocimab
Osocimab (BAY 1213790) is a potent anti-FXIa antibody with a Ki value of 2.4 nM and an EC50 value of 0.2 nM.Osocimab may reduce thrombosis through FXI inhibition.Osocimab is often used as an XI factor inhibitor, has an inhibitory effect on thrombin generation, has an anticoagulant effect, and is used in the study of thromboembolic diseases. Thromboembolic Diseases
Product Specifications
CAS Number
2056878-75-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
FXR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-272029 100 mg
Piperazin-1-yl- (tetrahydro-furan-2-yl) -methanone
Sign In for Pricing
View Details 
CSB-EP001898HUe1-01 20 µg
Recombinant Human Serum amyloid P-component (APCS)
Sign In for Pricing
View Details CSB-EP001898HUe1-02 100 µg
Recombinant Human Serum amyloid P-component (APCS)
Sign In for Pricing
View Details 
CSB-EP001898HUe1-03 1 mg
Recombinant Human Serum amyloid P-component (APCS)
Sign In for Pricing
View Details